Level Bio Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
10
- Stock Symbol
-
LEVBIO
- Investments
-
1
- Share Price
-
$0.02
- (As of Thursday Closing)
Level Bio General Information
Description
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
Contact Information
Website
www.levelbio.seCorporate Office
- Västra Finnbodavägen 4B
- Nacka
- 131 30 Stockholm
- Sweden
Corporate Office
- Västra Finnbodavägen 4B
- Nacka
- 131 30 Stockholm
- Sweden
Level Bio Stock Performance
As of 19-Nov-2026, Level Bio’s stock price is $0.02. Its current market cap is $1.65M with 68.4M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.02 | $0.02 | $0.02 - $0.06 | $1.65M | 68.4M | 45.7K |
Level Bio Financials Summary
As of 30-Sep-2026, Level Bio has a trailing 12-month revenue of $3.86M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,484 | 2,062 | 1,593 | |
| Revenue | 3,859 | 3,294 | 2,373 | 2,455 |
| EBITDA | (46) | (132) | (558) | (709) |
| Net Income | 487 | (360) | (744) | (892) |
| Total Assets | 1,965 | 1,527 | 1,393 | 1,910 |
| Total Debt | 0 | 217 | 128 | 111 |
Level Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Level Bio Patents
Level Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170239653-A1 | Device and method for conducting direct quantitative real time pcr | Inactive | 05-Feb-2016 | ||
| US-9273351-B2 | Device and method for conducting direct quantitative real time pcr | Active | 24-Sep-2010 | ||
| US-20130157276-A1 | Device and method for conducting direct quantitive real time pcr | Active | 24-Sep-2010 | ||
| WO-2012037978-A1 | New device and method for conducting direct quantitive real time pcr | Inactive | 24-Sep-2010 | ||
| US-20060199261-A1 | For a microtitreplate or an array of separate test tubes; cooling or heating gas or liquid is spread evenly around each well especially when centrifuging | Active | 19-Dec-2002 | B01L9/523 |
Level Bio Signals
Level Bio Acquisitions (1)
Level Bio’s most recent deal was a Merger/Acquisition with CyberGene. The deal was made on 01-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CyberGene | 01-Jun-2021 | Merger/Acquisition | Diagnostic Equipment |
Level Bio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Level Bio Exits (1)
Level Bio’s most recent exit was on 01-Jun-2021 from CyberGene. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CyberGene | 01-Jun-2021 | Completed |
|
Level Bio Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Alphahelix Technologies | Nacka, Sweden | 2011 | |
| Techtum Lab | Nacka, Sweden | 1975 |
Level Bio FAQs
-
When was Level Bio founded?
Level Bio was founded in 1998.
-
Where is Level Bio headquartered?
Level Bio is headquartered in Stockholm, Sweden.
-
What is the size of Level Bio?
Level Bio has 10 total employees.
-
What industry is Level Bio in?
Level Bio’s primary industry is Biotechnology.
-
Is Level Bio a private or public company?
Level Bio is a Public company.
-
What is Level Bio’s stock symbol?
The ticker symbol for Level Bio is LEVBIO.
-
What is the current stock price of Level Bio?
As of 19-Nov-2026 the stock price of Level Bio is $0.02.
-
What is the current market cap of Level Bio?
The current market capitalization of Level Bio is $1.65M.
-
What is Level Bio’s current revenue?
The trailing twelve month revenue for Level Bio is $3.86M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process